CSPC Pharmaceutical Group Ltd (1093)

7.65 -0.11 (-1.42%)
Closed HKD Disclaimer

1093 Financial Summary

CSPC Pharmaceutical Group Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 15,610.03 million compared to CNY 13,822.28 million a year ago. Net income was CNY 2,966.21 million compared to CNY 3,062.57 million a year ago. Basic earnings per share from continuing operations was CNY 0.2489 compared to CNY 0.2562 a year ago. Diluted earnings per share from continuing operations was CNY 0.2489 compared to CNY 0.2562 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
1093
Gross margin TTM 74.02%
Operating margin TTM 22.37%
Net Profit margin TTM 18.58%
Return on Investment TTM 19.34%
Total Revenue
Net Income
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Revenue 7,736.13 7,873.89 7,225.12 6,819.48
Gross Profit 5,527.52 5,810.96 5,479.64 5,130.79
Operating Income 1,654.16 1,825.26 1,628.11 1,526.62
Net Income 1,561.69 1,404.52 1,269.88 1,272.73
Clear All
0Selected
Please try another search
1093
Quick Ratio MRQ 2.36
Current Ratio MRQ 2.7
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 2.43%
Total Assets
Total Liabilities
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Assets 38,838.51 34,741.58
Total Liabilities 9,423.37 8,754.90
Total Equity 29,415.14 25,986.67
Clear All
0Selected
Please try another search
1093
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow 0.00%
Cash
Net Change in Cash
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Cash From Operating Activities 4,636.63
Cash From Investing Activities -637.33
Cash From Financing Activities -2,196.61
Net Change in Cash 1,800.25
Clear All
0Selected
Please try another search

* In Millions of CNY (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.